Statistics for Acceptability and tolerability of longacting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV IMPAACT 2017MOCHA a second analysis of a phase 12 multicentre openlabel noncomparative dos